Literature DB >> 9618307

Adenosine receptor mediates motility in human melanoma cells.

E C Woodhouse1, D F Amanatullah, J A Schetz, L A Liotta, M L Stracke, T Clair.   

Abstract

Cell motility is an essential component of tumor progression and metastasis. A number of factors, both autocrine and paracrine, have been found to influence cell motility. In the present study, adenosine and adenine nucleotides directly stimulated chemotaxis of A2058 melanoma cells in the absence of exogenous factors. Three adenosine receptor agonists stimulated motility in the melanoma cells and two adenosine receptor antagonists strongly inhibited the chemotactic response to both adenosine and AMP. The chemotactic stimulation by adenosine and AMP was pertussis toxin sensitive. Otherwise unresponsive Chinese hamster ovary cells which were transfected with the adenosine A1 receptor cDNA acquired the direct, pertussis toxin sensitive, chemotactic response to adenosine, and this response was inhibited by adenosine receptor antagonists. These findings demonstrate that adenosine and adenine nucleotides are capable of stimulating chemotaxis of tumor cells mediated through an adenosine receptor, probably of the A1 subtype. The possibility of antimetastatic therapies based on inhibition of adenosine receptor activity is raised.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618307     DOI: 10.1006/bbrc.1998.8714

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.

Authors:  Li Wang; Xuerui Zhou; Tingting Zhou; Dong Ma; Sifeng Chen; Xiuling Zhi; Lianhua Yin; Zhimin Shao; Zhouluo Ou; Ping Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-02       Impact factor: 4.553

2.  Diminution in adenine nucleotide hydrolysis by platelets and serum from rats submitted to Walker 256 tumour.

Authors:  Andréia Buffon; Vanessa B Ribeiro; Alessandra S Schanoski; João J F Sarkis
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

3.  CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver.

Authors:  S Cohen; S M Stemmer; G Zozulya; A Ochaion; R Patoka; F Barer; S Bar-Yehuda; L Rath-Wolfson; K A Jacobson; P Fishman
Journal:  J Cell Physiol       Date:  2011-09       Impact factor: 6.384

Review 4.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

5.  Involvement of ecto-5'-nucleotidase/CD73 in U138MG glioma cell adhesion.

Authors:  Angélica Regina Cappellari; Gabriela Jouglard Vasques; Luci Bavaresco; Elizandra Braganhol; Ana Maria Oliveira Battastini
Journal:  Mol Cell Biochem       Date:  2011-08-21       Impact factor: 3.396

6.  The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells.

Authors:  Emilie C Lefort; Jonathan Blay
Journal:  Clin Exp Metastasis       Date:  2011-02-05       Impact factor: 5.150

7.  RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion.

Authors:  Xiuling Zhi; Sifeng Chen; Ping Zhou; Zhimin Shao; Li Wang; Zhouluo Ou; Lianhua Yin
Journal:  Clin Exp Metastasis       Date:  2007-06-21       Impact factor: 5.150

8.  Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior.

Authors:  Ernest Y Tan; Michelle Mujoomdar; Jonathan Blay
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

9.  CD73: an emerging checkpoint for cancer immunotherapy.

Authors:  Siqi Chen; Derek A Wainwright; Jennifer D Wu; Yong Wan; Daniela E Matei; Yi Zhang; Bin Zhang
Journal:  Immunotherapy       Date:  2019-06-21       Impact factor: 4.196

10.  Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis.

Authors:  J Z Zhou; M A Riquelme; X Gao; L G Ellies; L Z Sun; J X Jiang
Journal:  Oncogene       Date:  2014-05-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.